Actively Recruiting
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
Led by University of Texas at Austin · Updated on 2025-02-10
20
Participants Needed
1
Research Sites
112 weeks
Total Duration
On this page
Sponsors
U
University of Texas at Austin
Lead Sponsor
E
Emory University
Collaborating Sponsor
AI-Summary
What this Trial Is About
Transcranial magnetic stimulation (TMS) interventions could feasibly strengthen residual corticospinal tract (CST) connections and promote poststroke hand motor recovery. To maximize the effects of such interventions, they must be delivered during brain activity patterns during which TMS best activates the residual CST and enhances its neural transmission. This approach is termed brain state-dependent TMS. The investigators have recently developed a machine learning framework that identifies personalized brain activity patterns reflecting strong CST activation in neurotypical adults. In this study, the investigators will apply this framework to the poststroke brain for the first time. They will also evaluate relationships between this framework's ability to detect strong and weak CST activation states and measures of CST pathway integrity. Participants will visit the laboratory for two days of testing that are separated by at least one night of sleep. On Day 1, participants will provide their informed consent. The MacArthur Competence Assessment Tool and the Frenchay Aphasia Screening Test will be used to evaluate consent capacity and confirm the presence of expressive aphasia as needed. Afterwards, participants will complete eligibility screening and clinical assessment of upper extremity motor impairment, motor function, and disability using the Upper Extremity Fugl-Meyer Assessment, the Wolf Motor Function Test, and the Modified Rankin Scale. Participants will then be screened for the presence of residual CST connections from the lesioned hemisphere to the affected first dorsal interosseous muscle. Recording electrodes will be attached to this muscle in order to record TMS-evoked twitches in these muscles. During this procedure, single-pulse TMS will be applied to each point of a 1 cm resolution grid covering primary and secondary motor areas of the lesioned hemisphere at maximum stimulator output. If TMS reliably elicits a muscle twitch in the affected first dorsal interosseous, that participant will be considered to have residual CST connections and will be eligible for the full study. If no muscle twitch is observed, the participant will not be eligible for the full study. Afterwards, recording electrodes will be removed and the participant will leave the laboratory. On Day 2, participants will return to the laboratory. The investigators will confirm continued eligibility and place recording electrodes on the scalp using a swim-type cap. The investigators will also place recording electrodes on the affected first dorsal interosseous as well as the affected abductor pollicis brevis and extensor digitorum communis muscles. After identifying the scalp location at which TMS best elicits muscle twitches in the affected first dorsal interosseous muscle, the investigators will determine the lowest possible TMS intensity that such evokes muscle twitches at least half of the time. Then, the investigators will deliver 6 blocks of 100 single TMS pulses while participants rest quietly with their eyes open. Stimulation will be delivered at an intensity that is 20% greater than the lowest possible TMS intensity that evokes muscle twitches at least half the time. Afterwards, all electrodes will be removed, participation will be complete, and participants will leave the laboratory. The investigators will recruit a total of 20 chronic stroke survivors for this study.
CONDITIONS
Official Title
Identifying Personalized Brain States Predicting Residual Corticospinal Tract Output After Stroke
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Presence of residual upper extremity weakness defined by any of the following: Fugl-Meyer Upper Extremity Score less than 66, Wolf Motor Function Test Score less than 70, affected hand 9-Hole Peg Test performance at least 10% worse than unaffected hand, or affected hand grip performance at least 10% worse than unaffected hand
- Stroke (ischemic or hemorrhagic) occurred at least 6 months before participation
- Willingness and ability to provide informed consent
- Presence of residual corticospinal connections to an affected upper extremity muscle as shown by muscle response to brain stimulation
You will not qualify if you...
- History of neurological disease or injury other than stroke
- Contraindications to TMS including cardiac pacemaker, cochlear implant, cortical stimulator, deep brain stimulator, vagus nerve stimulator, cervical spine epidural stimulation, ventriculoperitoneal shunt, or ferromagnetic metallic implants above the seventh cervical vertebra
- Seizure in the last 12 months while taking anti-epilepsy medication
- History of adverse reactions to TMS or peripheral nerve stimulation
- Current, suspected, or planned pregnancy
- Recent medication changes within the last month
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Texas at Austin
Austin, Texas, United States, 78712
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
NA
Model
CROSSOVER
Primary Purpose
BASIC_SCIENCE
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here